Cataract News and Research

Latest Cataract News and Research

Financial incentives may influence frequency of cataract surgery in Medicare and VA health system

Patients seen at private facilities reimbursed by Medicare were more than 550 percent more likely to have routine cataract surgery than those who received their care from the Department of Veterans Affairs, a strong indication that the frequency of cataract surgery may be responsive to financial incentives to either or both the medical facility and the physicians who perform the procedure.

19 Mar 2010

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Manitobans with wet age-related macular degeneration (AMD) received a dose of good news. The Manitoba government announced that Lucentis (ranibizumab injection) will soon be funded through a centralized vision program, effective June 1, 2010.

18 Mar 2010

OVD issue highlights prevalence of eye problems in general population

In the latest issue of Optometry & Vision Development (OVD), Dr. Dominick Maino, editor of OVD, notes that: "In 2010 there are 9 million people with lazy eye and 18 million individuals with eye-turns

17 Mar 2010

$TLCVision to incorporate TearLab Osmolarity System to study DED in refractive surgery centers$

TLCVision to incorporate TearLab Osmolarity System to study DED in refractive surgery centers

OccuLogix, Inc., dba TearLab Corporation, announced today that TLCVision Corporation, North America's premier eye care services company, will be incorporating the TearLab™ Osmolarity System in eight of its U.S. refractive surgery centers to study Dry Eye Disease symptoms as they relate to LASIK surgery.

11 Mar 2010

FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients

Abbott announced today it has received U.S. Food and Drug Administration approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia.

10 Mar 2010

Some anti-depressant drugs associated with increased chance of developing cataracts: Study

Some anti-depressant drugs are associated with an increased chance of developing cataracts, according to a new statistical study by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute and McGill University.

9 Mar 2010

ISTA Pharmaceuticals' sNDA for once-daily XiDay: FDA assigns PDUFA action date

ISTA Pharmaceuticals, Inc., today announced the Company's supplemental New Drug Application (sNDA) for once-daily XiDay™ (bromfenac ophthalmic solution) has been accepted for review by the U.S. Food and Drug Administration (FDA).

8 Mar 2010

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today said that 24-month data from the FAME Phase 3 study for Iluvien presented at Angiogenesis 2010 included additional efficacy and safety data that reinforced the positive top-line results reported in December 2009 by pSivida and its licensee, Alimera Sciences, Inc.

4 Mar 2010

Patient Safety Authority highlights analysis of data related to insulin medication errors

Pennsylvania healthcare facilities submitted over 2,600 event reports that involved the use of insulin products to the Patient Safety Authority where more than 52 percent led to situations in which a patient may have or actually received the wrong dose or no dose of insulin. The data raises awareness of a broader issue that is highlighted in the 2010 March Pennsylvania Patient Safety Advisory.

3 Mar 2010

Advances in surgical technology enable surgeons to perform many operations as outpatient procedures

Nearly 58 percent of the surgeries performed in hospitals were done as outpatient procedures, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

26 Feb 2010

Alcon reports 2009 fourth quarter results

Alcon, Inc. reported that global sales rose 14.5 percent to $1.72 billion for the fourth quarter of 2009, or an 8.5 percent increase excluding the impact of foreign exchange fluctuations. Reported net earnings for the fourth quarter of 2009 grew 8.0 percent to $458 million, or $1.51 per diluted share.

11 Feb 2010

Cholesterol lowering drugs also reduce risk of developing cataracts

Statins, a class of drugs used to lower cholesterol levels, have been successfully fighting heart disease for years. A new study from Tel Aviv University has now found that the same drugs cut the risks of cataracts in men by almost 40%.

10 Feb 2010

Hoya reports financial results for quarter ended December 31, 2009

Hoya Corporation today announced financial results for the third quarter ended December 31, 2009. Net sales were 106.8 billion yen for the quarter, a 5.2% decrease from 112.7 billion yen in the same period last year. Operating income was 18.9 billion yen, a 13.8% increase from 16.6 billion yen in the same period last year, mainly due to increase in orders and productivity. Compared to the second quarter ended September 30, 2009, sustained recovery in orders since April resulted in an increase of both net sales and operating income.

9 Feb 2010

Paloma Pharmaceuticals receives FDA approval to enter Phase I studies with P529

Paloma Pharmaceuticals, Inc. announced today that it has received acceptance of its IND to enter Phase I studies with Palomid 529 (P529) in patients with age-related macular degeneration (AMD).

5 Feb 2010

Virtual tool enhances cataract surgery training programs

The Massachusetts Eye and Ear Infirmary Cataract Surgery Trainer, a virtual training tool which helps to train physicians to perform cataract surgery, has been shown to enhance teaching in cataract surgery when compared to traditional teaching methods.

3 Feb 2010

Abbott declares quarterly dividend of 40 cents per share

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2009.

27 Jan 2010

This year's Aegean Cornea Conference to celebrate 20th Anniversary of LASIK Surgery

The Institute of Vision and Optics at the University of Crete announced today that this year’s Aegean Cornea Conference will celebrate the 20th Anniversary of LASIK surgery. The biennial event will feature world leaders in cornea, cataract and refractive surgery as well as presentations on medical and scientific breakthroughs in the field.

18 Jan 2010

IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090

Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it has initiated its Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 in patients undergoing cataract surgery.

6 Jan 2010

Bausch & Lomb launches Crystalens AO intraocular lens

Bausch & Lomb today announced that it is launching the Crystalens® AO, the first aberration-free accommodating intraocular lens (IOL) with aspheric optics to cataract surgeons worldwide.

4 Jan 2010

JAMA: New series on caring for the aging patient

To assist physicians in caring for a patient demographic that is rapidly growing in size, JAMA is launching a new series, "Care of the Aging Patient: From Evidence to Action."

29 Dec 2009

Cataract News and Research

Latest Cataract News and Research

Financial incentives may influence frequency of cataract surgery in Medicare and VA health system

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

OVD issue highlights prevalence of eye problems in general population

TLCVision to incorporate TearLab Osmolarity System to study DED in refractive surgery centers

FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients

Some anti-depressant drugs associated with increased chance of developing cataracts: Study

ISTA Pharmaceuticals' sNDA for once-daily XiDay: FDA assigns PDUFA action date

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

Patient Safety Authority highlights analysis of data related to insulin medication errors

Advances in surgical technology enable surgeons to perform many operations as outpatient procedures

Alcon reports 2009 fourth quarter results

Cholesterol lowering drugs also reduce risk of developing cataracts

Hoya reports financial results for quarter ended December 31, 2009

Paloma Pharmaceuticals receives FDA approval to enter Phase I studies with P529

Virtual tool enhances cataract surgery training programs

Abbott declares quarterly dividend of 40 cents per share

This year's Aegean Cornea Conference to celebrate 20th Anniversary of LASIK Surgery

IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090

Bausch & Lomb launches Crystalens AO intraocular lens

JAMA: New series on caring for the aging patient

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cataract News and Research

Latest Cataract News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in